Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This is a single arm pilot trial to evaluate the feasibility of using a simvastatin
intervention, and to evaluate its effects on cancer progression, among 20 patients with
platinum-sensitive ovarian cancer, treated with carboplatin and liposomal doxorubicin at
Cedars-Sinai Medical Center.